Epitopoietic Research
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
745 5th Ave Ste 500, New York, New York,...Phone Number
(646) 768-4246Website
www.ercimmunotherapy.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Epitopoietic Research
Epitopoietic Research Corporation (ERC) is a clinical stage biopharmaceutical company focused on developing immunotherapy treatments for cancer, particularly targeting Glioblastoma multiforme (GBM) using its patented Gliovac/ERC1671 vaccine. The company employs a unique approach that utilizes a combination of autologous and allogeneic tumor cells to stimulate the patient's immune system for effective cancer cell rejection. ERC aims to enhance patient quality of life and increase life expectancy while minimizing side effects associated with conventional treatments. Additionally, ERC is expanding its innovative immunotherapy solutions to include emerging infectious diseases, demonstrating its versatility in addressing various health challenges.Explore more
Popular SearchesEpitopoietic Research CorpSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Epitopoietic Research your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Epitopoietic Research has recently received funding, and reach out quickly before it becomes old news!
Check out if Epitopoietic Research is spiking on competitors!
Earning: See what the market has to say on Epitopoietic Research recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Epitopoietic Research
Product Launch: Get notified when Epitopoietic Research launches new products
Funding: Get notified immidiatlly once Epitopoietic Research has new funding data
Epitopoietic Research, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Epitopoietic Research had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Epitopoietic Research
Compare insights from companies similar to Epitopoietic Research, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Epitopoietic Research
<$5M
11-50
Private
-
-
N/A
Epitopoietic Research Tech Stack
A closer look at the technologies used by Epitopoietic Research
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Epitopoietic Research
Sign Up For FreeTo access detailed company insights
Epitopoietic Research Corporation (ERC) is a clinical stage biopharmaceutical company focused on developing immunotherapy treatments for cancer, particularly targeting Glioblastoma multiforme (GBM) using its patented Gliovac/ERC1671 vaccine. The company employs a unique approach that utilizes a combination of autologous and allogeneic tumor cells t... Read More
